27
Jun
2024
14:00
BST
09:00
EDT
Webinar
Anticoagulation for Atrial Fibrillation: Considerations for Patients With Cancer
-
Views:
2915
-
Likes:
19
Overview
In the next instalment of this cardio-oncology broadcast series, Prof Husam Abdel-Qadir (Women’s College Hospital, CA), Prof Dan Lenihan (Saint Francis Healthcare System, US) and Prof Joe Carver (University of Pennsylvania, US) discuss anticoagulation therapy for atrial fibrillation in patients with cancer.
Join us to enhance your knowledge and skills in managing atrial fibrillation in patients with cancer, ensuring that these patients receive the most effective and safest care possible.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Support Statement
This is an independent activity run by the International Cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by AstraZeneca, BeiGene, BMS/Pfizer Alliance, Eli Lilly and Sumitomo Pharma through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
Faculty:
Husam Abdel-Qadir
Dan Lenihan
Joe Carver
This broadcast is supported by
Faculty Biographies
Husam Abdel-Qadir
Prof Husam Abdel-Qadir is a Cardiologist at Women’s College Hospital, Toronto, CA. Prof Abdel-Qadir's primary clinical and research focus is on the cardiovascular health of people with cancer, particularly breast cancer and he leads a research programme on the management and outcomes of people with atrial fibrillation.
Prof Abdel-Qadir graduated from the University of Toronto’s medical school with the Silver Medal and completed residencies in Internal Medicine and Cardiology.
Dan Lenihan
Dr Dan Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Joe Carver
Dr Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.